Dynavax Technologies Corp. (DVAX)
15.62
+0.02
(+0.13%)
USD |
NASDAQ |
Jan 15, 16:00
15.62
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies SG&A Expense (TTM): 179.71M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.70B |
| Amicus Therapeutics, Inc. | 353.07M |
| Agios Pharmaceuticals, Inc. | 180.37M |
| Hyperion DeFi, Inc. | 15.85M |
| Edgewise Therapeutics, Inc. | 36.80M |